The administration of RdCVF protein would restore rod-to-cone signaling preventing the secondary degeneration of cones and thus transforming retinitis pigmentosa in a type of night blindness associated with moderate visual impairment, independent from the causative mutations in any of the 60 known genes [66–68]. The gene discussed is NXNL1; the disease is retinitis pigmentosa.